Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)
NCT05085990
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-muscle Invasive Bladder Cancer
Interventions
BIOLOGICAL:
TARA-002
Sponsor
Protara Therapeutics